Danicopan with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuria

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 7.15 MB)

  Published:

  23 October 2024

• Final draft guidance committee papers (PDF 1.2 MB)

  Published:

  23 October 2024